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Abstract
High-throughput sequencing of targeted genomic loci in large populations is an effective approach for evaluating the
contribution of rare variants to disease risk. We evaluated the feasibility of using in-solution hybridization-based target
capture on pooled DNA samples to enable cost-efficient population sequencing studies. For this, we performed pooled
sequencing of 100 HapMap samples across ,600 kb of DNA sequence using the Illumina GAIIx. Using our accurate variant
calling method for pooled sequence data, we were able to not only identify single nucleotide variants with a low false
discovery rate (,1%) but also accurately detect short insertion/deletion variants. In addition, with sufficient coverage per
individual in each pool (30-fold) we detected 97.2% of the total variants and 93.6% of variants below 5% in frequency.
Finally, allele frequencies for single nucleotide variants (SNVs) estimated from the pooled data and the HapMap genotype
data were tightly correlated (correlation coefficient .= 0.995).
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Introduction
Over the past few years, genome wide association studies
(GWAS) have uncovered hundreds of common variants associated
with various traits and common diseases[1]. The discovery of
these disease-associated variants has shed light on previously
unknown genes and disease mechanisms. However, for many
diseases, a large proportion of the genetic variation underlying
disease risk remains to be discovered. There is growing evidence
that some of this ‘missing heritability’ could be explained by the
influence of collections of rare variants (MAF ,0.05) which have
not been captured by current genotyping chips used in most
GWAS[2,3].
The contribution of rare variants to phenotypic variation can be
effectively surveyed through large-scale population re-sequencing
studies. Due to high costs, most re-sequencing studies have been
limited to sequencing the coding regions of a small number of
genes using Sanger sequencing[4]. The availability of high-
throughput target capture methods combined with the massive
throughput of next-generation sequencing platforms has made it
possible to interrogate thousands of genomic loci in a cost effective
manner[5,6]. In fact, the costs are so low that when one factors
only the price to run the sequencer and the production of raw base
reads, it is feasible to sequence megabases of DNA in thousands of
individuals using a small number of sequencing runs. The
budgetary bottleneck for such studies is not the sequencing cost
but the cost of sample preparation for each individual sample prior
to sequencing. Assuming that it costs ,250 dollars for target
capture and library preparation, the sample preparation cost for a
project with 1000 individuals would be $250,000. A simple
strategy to reduce the per-sample cost while utilizing the massive
capacity of current sequencers is to use DNA pooling prior to
target capture and sample preparation. DNA pooling was
previously proposed as a strategy for reducing the cost of large-
scale genotyping-based disease association studies[7]. However,
the difficulty in accurately measuring allele frequencies from
intensity data has limited the use of this strategy. Unlike pooled
genotyping, pooled DNA sequencing not only provides digital
allele counts for each variant but can also be used to detect novel
sequence variants. Several recent studies have demonstrated the
potential of pooled sequencing using next-generation sequencing
platforms for identifying disease associated rare mutations [8,9].
There are two main requirements for the successful utilization
of DNA pooling for large-scale resequencing studies. Prior to
sequencing, it is important to minimize various biases that cause
unequal representation of DNA from individuals in the pooled
sequencing library. Such pooling imbalances can result in
inaccurate estimates of allele frequencies as well as make it
difficult to identify rare variants. Post-sequencing, it is essential to
identify rare and common variants with low false positive and false
negative rates. Detection of rare variants from pooled sequencing
data represents a particularly challenging task since the signal for
rare variants can be difficult to distinguish from sequencing
errors[10].
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pooling is necessary to reduce imbalances, biases introduced in the
target-capture step need to be minimized as well. In comparison to
PCR-based enrichment strategies which are sensitive to DNA
quality and can introduce biases[11], in-solution sequence
hybridization is less likely to introduce imbalances in the pooled
DNA sequencing library. In this study, we evaluated the feasibility
of in-solution sequence hybridization-based enrichment of geno-
mic loci applied to pooled genomic DNA. We sequenced ,600
kilobases of coding sequence across the human genome in 100
HapMap samples using 5 pools with 20 samples each. We used
Agilent in-solution enrichment for target enrichment and
sequenced the pooled libraries using the Illumina Genome
Analyzer. Using a statistical variant caller for pooled sequencing
data, CRISP[12], we were able to detect single nucleotide variants
with high sensitivity and specificity. Comparison of the pooled
allele frequency estimates to data from the HapMap and 1000
Genomes project demonstrated the ability to accurately estimate
allele frequencies from pooled sequencing. In addition, we were
also able to accurately identify short insertion/deletion variants
from the pooled data.
Results
Study design and sequencing
We targeted 594 Kb of DNA sequence from the coding regions
of genes that were also sequenced in the 1000 Genomes exon pilot
project[12] by solution based hybridization capture (Table S2).
For sequencing, we selected 100 HapMap samples: 20 Utah
residents with ancestry from northern and western Europe (CEU),
20 Han Chinese in Beijing, China (CHB), 20 Tuscans in Italy
(TSI) and 40 Yoruba in Ibadan, Nigeria (YRI)[13] (Table S1). The
samples were pooled by population with each pool consisting of 20
individuals. We chose a moderate pool size of 20 so that the allele
frequency of a singleton variant (1/40) was well above the average
sequencing error rate of an Illumina GAIIx, which we observe to
be between 0.5–1%. Pooled samples were carried through the
library preparation process as well as the sequence enrichment
process following the normal protocol, as though they were from a
single genomic sample. The 5 pools were sequenced using DNA
barcodes on two lanes of the Illumina GAIIx using 55 bp paired-
end reads.
Accuracy of SNV detection and allele frequency estimates
Reads for each pool were aligned to the human genome
reference sequence.
(HG18) using the BWA aligner[14]. We generated an average
of 695 Mb of sequence data for each pool, ,55% of which
mapped directly on our 594 Kb of target sequence (Table 1). On
average each pool had 683-fold coverage across the targets,
translating to an average of 34-fold coverage per individual. For
calling variants, we utilized a statistical method, CRISP, that is
designed for variant detection using sequence data from multiple
DNA pools[15]. Within the targeted regions, we detected 2849
variants (2749 SNVs and 100 indels) using this method.
To assess the accuracy of the SNV calls and the allele frequency
estimates, we generated a merged set of variants and genotypes
using data on the same set of 100 samples from the HapMap and
the 1000 Genomes projects (HM+1KG dataset). Further, we
restricted the analysis to the 470 kb of sequence that overlapped
with the exon capture boundaries of the 1000 Genomes pilot
project. We compared the SNVs in each pool to the SNVs
reported in the HM+1KG dataset for the corresponding 20
samples in the pool. Summed across the 5 pools, we identified
4588 SNVs, 4327 of which matched the HM+1KG dataset
(Table 2). Across the 470 kb of sequence, we failed to detect 490
SNVs called in the HM+1KG dataset. Many of these missed
variants are likely due to inadequate sequencing depth in our data.
Indeed, false negative rates reduced to 6% (276 variants) and 2.8%
(82 variants) when considering bases with at least 10 and 30-fold
average coverage per sample respectively (Table 2). Not
surprisingly, the majority of these variants were of low frequency
with 266 of the variants at 10-fold coverage and 81 of the variants
at 30-fold coverage being at an allele frequency of 5% or lower.
This represents a sensitivity of detection of 86.3% at 10-fold and
93.4% at 30-fold coverage per individual for variants present on 2
or fewer chromosomes in the pool. Next, we assessed the false
discovery rate of our SNV calls. Because of missing data in the
1000 genomes dataset for three of the pools, we only used the TSI
pool and one of the YRI pools for this analysis. Taking into
account all bases in the two pools, we identified 112 SNVs not
reported in the HM+1KG dataset. Of these, 42 (37.5%) were
previously reported in dbSNP (v130) lending support for them to
be true variants. The majority (74.1%) of the false positives were of
low frequency (,=5%). Of the variants estimated to be of 5%
frequency or lower in our data, 23 were present in dbSNP. For the
remaining 70 sites, we visually inspected aligned sequence reads
from the 1000 Genomes project to evaluate if they represented
potentially real variants. 49 of the 70 sites appeared to be true
polymorphisms, 8 sites had little or no coverage for one or more
samples. The remaining 13 sites were clearly false positives in our
dataset, 6 of the 13 sites had an estimated allele frequency of 5% or
lower. Assuming that half of the low coverage sites represent true
variants, we estimate a false discovery rate of 0.9% for our pooled
variant calls.
We then compared the allele frequencies calculated using the
read counts in the pools to the actual allele frequencies determined
from the HM+1KG genotypes for each pool. The correlation
between the HM+1KG allele frequencies and the pooled estimates
was excellent with an r
2 correlation coefficient ranging from
0.995–0.997 across the five pools and very few outliers (Figure 1).
In addition, our estimated allele frequencies for the vast majority
of variants closely matched those from the HM+1KG with 80% of
the variants within 1/40
th and 94% within 1/20
th of the actual
frequency (Figure 2).
Detection of indel variants
The ability to detect short insertion/deletion variants from
pooled sequence data is useful, especially in coding regions of the
genome. Detection of short indels from next-generation sequenc-
ing data is challenging due to the difficulty in accurately aligning
Table 1. Capture Efficiency.
Total On Target Mean % of Bases




CEU 722 Mb 401.8 Mb (55.7%) 676 95.7%
CHB 709.6 Mb 388.7 Mb (54.8%) 654 94%
TSI 694.7 Mb 376.8 Mb (54.2%) 634 94.1%
YRI 1 606.4 Mb 327.8 Mb (54.1%) 552 92.6%
YRI 2 744.6 Mb 415.2 Mb (55.8%) 699 94.6%
doi:10.1371/journal.pone.0018353.t001
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reads. The statistical model underlying our variant caller, CRISP,
uses allele counts across multiple pools to differentiate variants
from sequencing errors and is also applicable to indels. CRISP
identified 100 indels (1–18 bp) in the 5 pools across the 570 kb of
target sequence. Only 19 indels were called in the 1000 genomes
exon project and of these 5 overlapped our target sequence. 4 of
these 5 indels matched indels called in our pooled data. An
additional 55 indels were identical to indels reported in dbSNP
(v130) or in the 1000 Genomes whole-genome low coverage
variant calls[13]. To validate the remaining indels, most of which
were low frequency variants, we visually examined the aligned
sequence reads for the 100 samples sequenced in the 1000
Genomes Project (see Materials and Methods) and found clear
evidence for 28 indels. Overall, 87 of the 100 pooled indel calls
were validated.
Cost Efficiency and power of Pooled Sequencing
We sought to compare the costs of a resequencing project
between pooled and individual sequencing using in-solution
hybridization. We evaluated two scenarios, a small and large
capture consisting of 750 kb and 3 Mb of total targeted regions
respectively on a small (400), modest (4,000) and large (20,000)
cohort of samples. The cost savings afforded by fewer library preps
represented an 11.8-fold decrease with the 750 kb capture and a
5.7 fold decrease for the 3 Mb capture when sequencing to 20x
coverage per sample (Table 3). The tight correlation between the
pooled allele frequency estimates and the individual-based allele
frequencies in our study shows that the increase in the variance of
the allele frequency due to the pooling noise is small. The ability to
sequence more samples can offset this slight increase in the
variance of the allele frequencies and substantially enhance the
power to detect associations across a range of minor allele
frequencies and effect sizes [16,17].
Discussion
Our results demonstrate that in-solution hybridization capture
of pooled DNA samples when combined with our variant calling
algorithm is a viable and cost-effective approach for performing
large-scale resequencing studies using high-throughput sequencing
technologies. Using pooled sequence data from 100 HapMap
samples we have shown that this approach minimizes false
positives, while being sensitive enough to detect even low
frequency alleles, a problem that has plagued previous pooling
and sequencing strategies. The ability to accurately detect rare
variants including indels from pooled sequence data can enable
large-scale sequencing studies of GWAS-associated genes or loci
for a particular disease to assess the collective contribution of low-
frequency functional variants.
Comparison of the pooled allele frequency estimates with actual
allele frequencies derived from HapMap or 1000 Genomes data
shows that the pooled allele frequencies are highly accurate. This
was clear proof that in-solution target capture introduced virtually
no biases in the pooled sequencing library. The ability to
accurately estimate allele frequencies from pooled sequencing
data is important since it can allow tests for association to be
performed directly from the pooled sequencing data without
additional genotyping. Furthermore, the ability to sequence a large
number of samples via pooling can substantially increase the
power to detect common and rare allele associations while still
providing a significant reduction in cost compared to individual
sequencing. An added benefit of the pooling approach is that only
150 ng of DNA per individual is required which can be important
for studies with a limited supply of genomic DNA.
In conclusion, the solution we have presented should prove to
be a cost-effective and easy to use approach for researchers looking
to perform large targeted re-sequencing studies examining both
common and rare variants.
Materials and Methods
Sample Preparation and Sequencing
We selected 100 samples (Table S1), 60 of which were from the
HapMap phase I+II (CEU, CHB, YRI 1) and the remaining 40
were genotyped as part of HapMap phase II (TSI, YRI 2). All 100
samples were slatedfor exome capture and sequencing as part of the
1000 Genome Project. DNA was obtained from the Coriell Institute
(Coriell Institute); all samples were quantifiedin quadruplicate using
picogreen (Life Technologies). Samples were pooled in equal molar
concentrationsinpoolsoftwentysampleseach.Thepoolswerethen
carried through the standard Illumina library preparation process





Variants Detected Detected False Positives
2 Detected False Positives
2
Pool HM & 1KG Variants Variants in dbSNP 130 False Negative3 Variants in dbSNP 130 False Negative3
at Targets in Pool in Pool Absent Included Absent Included
CEU 826 (283) 744 (213) 702 (213) 22 (15) 11 (6) 47 (45) 6.4% (19.2%) 479 (158) 16 (12) 10 (6) 17 (17) 3.4% (9.7%)
CHB 731 (268) 645 (194) 599 (191) 34 (29) 9 (7) 56 (56) 8.7% (24.7%) 410 (150) 25 (22) 8 (6) 22 (22) 5% (12.4%)
TSI 850 (377) 748 (287) 700 (280) 37 (33) 26 (15) 54 (53) 7.1% (16.2%) 460 (198) 29 (26) 24 (13) 10 (10) 1.9% (4.2%)
YRI 1 1194 (419) 1084 (338) 995 (324) 56 (50) 13 (6) 54 (50) 5.1% (13.2%) 551 (192) 31 (29) 11 (5) 17 (16) 2.9% (7.1%)
YRI 2 1216 (573) 1106 (482) 1041 (470) 33 (27) 15 (8) 65 (62) 6% (12.3%) 712 (332) 23 (19) 15 (8) 16 (16) 2.1% (4.5%)
Sum 4817 (1920) 4327 (1514) 4037 (1478) 182 (154) 74 (42) 276 (266) 6% (13.7%) 2612 (1030) 124 (108) 68 (38) 82 (81) 2.8% (6.4%)
The number in parentheses represents only variants at 5% or lower frequency in the dataset.
1- Statistics for variant sites which were sequenced to a depth of 10 or 30 fold per individual in the pooled dataset.
2- Variants calledinthepooleddatasetnotpresentineitherHapMap orthe1000GenomeProject.Variantswerefurther classifiedasbeingincludedorabsentindbSNPv130.
3- Variants called in the HapMap or 1000 Genome Project that were not called in our pooled dataset.
doi:10.1371/journal.pone.0018353.t002
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repair, A-tailing and ligation (New England Biolabs). SureSelect in-
solution hybridization was performed on the pooled samples using
the recommended protocol for a single genomic DNA sample.
Captured DNA was then sequenced using 55 bp PE multiplexed
read protocol on an Illumina GAIIx.
Figure 1. Comparison of pooled allele frequency estimates with actual allele frequencies. Scatter plots for each of the 5 pools (CEU, TSI,
CHB, YRI 1, YRI 2) of the estimated allele frequency as calculated by read counts from the sequence data plotted against the actual allele frequency
from either the HapMap or 1000 Genome project. Only sites that contained genotype information for all 20 individuals in that particular pool are
included. The insert displays the area of the graph representing 1–3 copies of the alternate allele as a jitter plot. In both graphs, the points are shaded
to represent overall read coverage in our sequencing data at that site.
doi:10.1371/journal.pone.0018353.g001
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We used the BWA aligner[14] (v 0.5.7) to align the sequencing
reads for each pool to the NCBI reference human genome
sequence (ncbi36). Short read aligners such as BWA align each
read independently to the reference genome and are unable to
properly align reads that contain an insertion/deletion event close
to the start or end of the sequenced reads. Such misaligned reads
can result in false SNVs calls[18], make it difficult to call indels
and can be especially problematic for pooled sequencing data. To
rectify this problem, we utilized a simple realignment approach in
which the reads were aligned (without gaps) to an ‘indel-sensitive’
reference sequence generated from consensus sequences of indels
identified from the original BWA alignments. Alignments for reads
for which the new alignment, if any, was better than the original
BWA alignment were changed. This realignment procedure
changed the alignments of a small fraction of reads. The realigned
SAM files were used for variant calling using a recently developed
statistical algorithm called CRISP that uses information from
aligned sequence reads within each pool as well as across all
pools. For variant calling using CRISP, reads with low mapping
quality (,20) and base calls with a low quality score (,10) were
discarded. Variants (SNVs and indels) were identified using
CRISP on the aligned sequence reads for the 5 pools using the
default thresholds.To call a variant,CRISPrequired atleast4 reads
supporting the non-reference allele in one or more pools. The raw
and aligned Illumina reads and the set of variants identified in this
Figure 2. Error in the pooled allele frequency estimate for each variant. Histogram of the estimated error in measurement of allele
frequency from the pooled sequencing data. For each variant, the absolute difference between the pooled allele frequency estimate and the actual
allele frequency derived from the 1000 Genomes or HapMap data was computed.
doi:10.1371/journal.pone.0018353.g002
Table 3. Cost Estimates for Pooled Sequencing Projects.
750 Kb Capture Project 3 Mb Capture Project
Library Prep Total Project Total Project
Cost ($1000) Sequencing Cost ($1000) Cost Sequencing Cost ($1000) Cost
Number of Cost ($1000) Difference Cost ($1000) Difference
Samples Single Plex Pooled Single Plex Pooled Single Plex Pooled
400 110 5.5 2.7 112.7 8.2 10.7 120.7 16.2
4000 1100 55 26.8 1126.8 81.8 13.8 107 1207 162 7.5
10000 2750 137.5 66.9 2816.9 204.4 267.6 3017.6 405.1
Cost estimates based on a 100 bp HiSeq paired-end run with Illumina’s published reagent costs ($11,150 per flowcell) and an average throughput of 200 Gb per run.
Sample preparation includes $75 per samples for library prep and $200 per sample for solution based capture. All calculations for pooled sequencing assume 20
individuals per pool.
doi:10.1371/journal.pone.0018353.t003
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polymorphism.scripps.edu/datasets/PooledSequencing.
Variant Comparisons
For evaluating variant calls and allele frequencies, we use variant
calls and genotypes from the July 2010 release of the 1000 Genome
Project’s exon sequencing pilot project as well as indel calls from the
whole-genome low-pass pilot project[12]. To fill in missing
genotypes for some samples, we utilized genotypes from the
HapMap public release #28 (Phase I, II+III). Allele frequency
comparisons were limited to sites at which there was complete data
available for all 20 samples in the corresponding pool. We
downloaded aligned sequence reads generated using the Illumina
platform for the 100 samples sequenced in our study from the 1000
Genomes ftp website (ftp://ftp-trace.ncbi.nih.gov/1000genomes/
ftp/pilot_data/).
For each sample, we generated pileup files and used them for
visual confirmation of novel variant calls. All calculations and
figures were produced using a combination of Perl, Python and R.
Supporting Information
Table S1 A list of the 100 HapMap samples sequenced
in this study.
(XLS)
Table S2 An Excel file with the list of genomic regions
targeted in this study.
(XLS)
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